Anti-TNF-α polyclonal antibodies fab in severe sepsis

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1557, 2006-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-TNF-α therapy in ankylosing spondylitis

By Wendling Daniel Toussirot Eric

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 7, 2004-07 ,pp. : 1497-1507

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF-α therapies in chronic obstructive pulmonary diseases

By Antoniu Sabina A Mihaltan Florin Ulmeanu Ruxandra

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 8, 2008-08 ,pp. : 1203-1211

Informa Healthcare

Access to resources Recommend Favorite

Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy

By Barygina V.V.

Redox Report, Vol. 18, Iss. 3, 2013-05 ,pp. : 100-106

Maney Publishing

Access to resources Recommend Favorite

Anti-TNF antibodies linked to malignancy/serious infection

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Regional survey of tuberculosis risk assessment in rheumatology outpatients commencing anti-TNF-α treatment in relation to British Thoracic Society guidelines

By John H Buckley C Koh L Obrenovic K Erb N Rowe IF

Clinical Medicine, Vol. 9, Iss. 3, 2009-06 ,pp. : 225-230

Royal College Of Physicians

Access to resources Recommend Favorite